ESC Premium Access

The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial

Congress Presentation

About the speaker

Ms Anne de Veer

St Antonius Hospital, Nieuwegein (Netherlands (The))
0 follower

6 more presentations in this session

Impact of persistent pulmonary hypertension on the outcome of patients undergoing transcatheter aortic valve replacement

Speaker: Associate Professor K. Toutouzas (Athens, GR)


Normal blood pressure by ACC / AHA 2017 is associated with higher mortality in older adults with hypertension over 1 year. Results of the SARCOS study.

Speaker: Doctor J. Borges (Sao Paulo, BR)


Impact and predictive factors of bleeding complications in elderly patients admitted for an acute coronary syndrome: insights from the ANTARCTIC trial

Speaker: Doctor B. Lattuca (Nimes, FR)


Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation

Speaker: Doctor M. Vedovati (Perugia, IT)


Elderly females with acute coronary syndrome present frailty and readmissions more frequently than males

Speaker: Doctor L. Vicent Alaminos (Madrid, ES)


Access the full session

The ageing heart: a target for interventions and aggressive pharmacotherapy

Speakers: Ms A. de Veer, Associate Professor K. Toutouzas, Doctor J. Borges, Doctor B. Lattuca, Doctor M. Vedovati...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb